
MolMart offers state-of-the-art diagnostic genomic solutions in the UK, empowering individuals and families to make informed decisions about their health. Leveraging AI through their proprietary MAIA algorithm and MIRS scoring, MolMart provides comprehensive genetic testing for family planning (SureMart) and identifying genetic causes of health conditions (ExoMart). They utilize Illumina's Novaseq NGS platform for DNA sequencing. The company aims to make genomic insights affordable and accessible globally, focusing on precision, scalability, and actionable recommendations through personalized clinical reports and expert geneticist review.

MolMart offers state-of-the-art diagnostic genomic solutions in the UK, empowering individuals and families to make informed decisions about their health. Leveraging AI through their proprietary MAIA algorithm and MIRS scoring, MolMart provides comprehensive genetic testing for family planning (SureMart) and identifying genetic causes of health conditions (ExoMart). They utilize Illumina's Novaseq NGS platform for DNA sequencing. The company aims to make genomic insights affordable and accessible globally, focusing on precision, scalability, and actionable recommendations through personalized clinical reports and expert geneticist review.